Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case
Erik Oude Blenke, Eivor Örnskov, Christian Schöneich, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 112, Iss. 2, pp. 386-403
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Research Advances on the Stability of mRNA Vaccines
Feiran Cheng, Yi‐Ping Wang, Yu Bai, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 668-668
Open Access | Times Cited: 66
Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures
Sofie Meulewaeter, Gust Nuytten, Miffy H. Y. Cheng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 149-160
Open Access | Times Cited: 63
Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients
Arne Matteo Jörgensen, Richard Wibel, Andreas Bernkop‐Schnürch
Small (2023) Vol. 19, Iss. 17
Open Access | Times Cited: 53
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery
Mingdi Hu, Xiaoyan Li, Zhen You, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 50
Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA–Lipid Complexes
János Szebeni, Bálint Kiss, Tamás Bozó, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13147-13157
Open Access | Times Cited: 48
Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery
Marité Cárdenas, Richard A. Campbell, Marianna Yanez Arteta, et al.
Current Opinion in Colloid & Interface Science (2023) Vol. 66, pp. 101705-101705
Open Access | Times Cited: 43
Tailor made: the art of therapeutic mRNA design
Mihir Metkar, Christopher S. Pepin, Melissa J. Moore
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 67-83
Closed Access | Times Cited: 43
Quality assessment of LNP-RNA therapeutics with orthogonal analytical techniques
Jérémie Parot, Dóra Méhn, Hanna Jankevics, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 385-401
Open Access | Times Cited: 23
Exosome for mRNA delivery: strategies and therapeutic applications
Zoya Iqbal, Khurrum Rehman, Ayesha Mahmood, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Dynamic carriers for therapeutic RNA delivery
Simone Berger, Ulrich Lächelt, Ernst Wagner
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 20
Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol
Michael Neary, Lianne M. Mulder, Piotr S. Kowalski, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 812-833
Open Access | Times Cited: 18
Breaking the mold with RNA—a “RNAissance” of life science
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Overcoming thermostability challenges in mRNA–lipid nanoparticle systems with piperidine-based ionizable lipids
Kazuki Hashiba, Masamitsu Taguchi, Sachiko Sakamoto, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 16
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles
Matthew N. O’Brien, David A. Foley, Roger H. Pak, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
Factors Affecting Stability of RNA – Temperature, Length, Concentration, pH, and Buffering Species
Urmi Chheda, Selvi Pradeepan, Edward A. Esposito, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 2, pp. 377-385
Open Access | Times Cited: 38
Engineering nanomaterials for glioblastoma nanovaccination
Fatima Hameedat, Bárbara B. Mendes, João Conniot, et al.
Nature Reviews Materials (2024) Vol. 9, Iss. 9, pp. 628-642
Closed Access | Times Cited: 13
Stability indicating ion-pair reversed-phase liquid chromatography method for modified mRNA
Jonathan Currie, Jacob. R Dahlberg, Ester Lundberg, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 245, pp. 116144-116144
Open Access | Times Cited: 11
Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size
Ruimeng Shi, Xueli Liu, Yajuan Wang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Enhanced stability and efficacy of a lyophilized mRNA SARS-CoV-2 vaccine incorporating novel Ionizable lipids after one year storage at 25ºC
Elena Mata, Esther Broset, Carlos Matute, et al.
Research Square (Research Square) (2025)
Closed Access | Times Cited: 1
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
Biomimetic Nanoparticle Based Targeted mRNA Vaccine Delivery as a Novel Therapy for Glioblastoma Multiforme
Tanvir Ahmed, Kazi Tasnuva Alam
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Closed Access | Times Cited: 1
Enhancing vaccine stability in transdermal microneedle platforms
Suman Pahal, Feifei Huang, Parbeen Singh, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 1
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
Néha Datta, Charlotte Johnson, Dina Kao, et al.
Pharmacological Research (2023) Vol. 194, pp. 106870-106870
Open Access | Times Cited: 19
Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions
Anne-Gaëlle Reinhart, Anja Osterwald, Philippe Ringler, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 12, pp. 6492-6503
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top